日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Trop-2.2 directed radioimmunotherapy with 177Lu, 225Ac, and 212Pb in a pancreatic cancer model.

在胰腺癌模型中,使用 177Lu、225Ac 和 212Pb 进行 Trop-2.2 靶向放射免疫治疗。

Pratt Edwin C, Bauer David, Carter Lukas M, Cornejo Mike, Carrasco Sebastian E, Kaminsky Spencer, De Gregorio Roberto, Loor Angelique, Friedl Olivia, Bolaender Alexander, Chao Grace, Castanares Mark A, Collins Emily C, Lewis Jason S

Exploring the 89 Zr/ 177 Lu Theranostic Pairing with an Extracellular Matrix Targeted Radiopharmaceutical Against Triple Negative Breast Cancer.

探索 89Zr/177Lu 治疗诊断配对与细胞外基质靶向放射性药物治疗三阴性乳腺癌。

Hachey Justin, Viray Tara D, Carrasco Sebastian E, Carter Lukas M, Esposito Tullio V F, Matasci Mattia, Ravazza Domenico, Neri Dario, Lewis Jason S

Next-generation anti-DLL3 radiopharmaceuticals targeting high-grade neuroendocrine lung and prostate cancers

针对高级别神经内分泌肺癌和前列腺癌的新一代抗DLL3放射性药物

Tendler, Salomon; De Gregorio, Roberto; Balderes, Paul; Michel, Alexa L; Hoang, Tran T; Bauer, David; Tully, Kathryn M; Korsen, Joshua A; Lorenz, Ivo C; Khan, Abdul G; Carter, Lukas; Vergnolle, Olivia; Lebedeva, Irina V; Nyakatura, Elisabeth K; Bodei, Lisa; Morris, Michael J; Poirier, John T; Rudin, Charles M; Lewis, Jason S

Radiolabeling of CHX-A″-DTPA-Antibody Conjugates with [(89)Zr]ZrCl(4)

用[(89)Zr]ZrCl(4)对CHX-A″-DTPA-抗体偶联物进行放射性标记

Lyashchenko, Serge K; Esposito, Tullio V; Tran, Tuan; Bauer, David; Jones, Kali; Park, Hijin; Carter, Lukas M; Pillarsetty, Naga Vara Kishore; Lewis, Jason S

Chemical Tools to Characterize the Coordination Chemistry of Radionuclides for Radiopharmaceutical Applications

用于表征放射性核素配位化学的化学工具及其在放射性药物应用中的应用

Boros, Eszter; Comba, Peter; Engle, Jonathan W; Harriswangler, Charlene; Lapi, Suzanne E; Lewis, Jason S; Mastroianni, Simona; Mirica, Liviu M; Platas-Iglesias, Carlos; Ramogida, Caterina F; Tripier, Raphaël; Tosato, Marianna

Advances and challenges in precision imaging

精密成像技术的进展与挑战

Hricak, Hedvig; Mayerhoefer, Marius E; Herrmann, Ken; Lewis, Jason S; Pomper, Martin G; Hess, Christopher P; Riklund, Katrine; Scott, Andrew M; Weissleder, Ralph

Phase 1 dose-escalation trial using convection-enhanced delivery of radio-immunotheranostic 124I-Omburtamab for diffuse intrinsic pontine glioma

采用对流增强递送方式的放射免疫治疗诊断药物 124I-Omburtamab 治疗弥漫性内生性脑桥胶质瘤的 1 期剂量递增试验

Souweidane, Mark M; Bander, Evan D; Zanzonico, Pat; Reiner, Anne S; Manino, Nicole; Haque, Sofia; Carrasquillo, Jorge A; Lyashchenko, Serge K; Thakur, Sunitha B; Lewis, Jason S; Donzelli, Maria; Cheung, Nai-Kong V; Larson, Steven M; Kramer, Kim; Pandit-Taskar, Neeta; Dunkel, Ira J

Mucin-Targeted Antibodies for Ovarian Cancer

针对卵巢癌的粘蛋白靶向抗体

Lawson, Shaniqua A; Lewis, Jason S

[(45)Ti]Ti-HOPOs: Potential Complexes for the Development of (45)Ti PET Imaging Agents

[(45)Ti]Ti-HOPO:用于开发 (45)Ti PET 成像剂的潜在配合物

Saini, Shefali; Bhupathiraju, N V S Dinesh K; Jayawardana, Samith B; Phipps, Michael D; Lewis, Jason S; Francesconi, Lynn C; Wijeratne, Gayan B; Deri, Melissa A; Lapi, Suzanne E

Activity-based probes and chemical proteomics uncover the biological impact of targeting HMG-CoA Synthase 1 in the mevalonate pathway

基于活性的探针和化学蛋白质组学揭示了靶向甲羟戊酸途径中HMG-CoA合成酶1的生物学影响。

Yi, Sang Ah; Sun, Liang; Rao, Yi; Ordureau, Alban; Lewis, Jason S; An, Heeseon